Dashboard
Poor long term growth as Net Sales has grown by an annual rate of -6.76% and Operating profit at -23.20% over the last 5 years
With a fall in Operating Profit of -20.1%, the company declared Very Negative results in Sep 25
With ROE of 9, it has a Very Expensive valuation with a 3.3 Price to Book Value
Below par performance in long term as well as near term
Stock DNA
Specialty Chemicals
INR 5,385 Cr (Small Cap)
54.00
37
0.57%
0.26
5.08%
2.77
Total Returns (Price + Dividend) 
Latest dividend: 3 per share ex-dividend date: May-26-2025
Risk Adjusted Returns v/s 
Returns Beta
News

Archean Chemical Industries Ltd Surges 7.78% to Day's High of Rs 457.7 — Outperforms Sector by 6.52 Percentage Points
The Sensex declined 0.16% on 13 Nov 2026 while Archean Chemical Industries Ltd surged 7.78%, outperforming its Specialty Chemicals sector by 6.52 percentage points. This strong single-session gain stands out as a stock-specific event amid a broadly weak market backdrop.
Read More
Archean Chemical Industries Ltd is Rated Sell
Archean Chemical Industries Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 30 October 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 13 November 2026, providing investors with an up-to-date perspective on the company’s fundamentals, valuation, financial trends, and technical outlook.
Read More
Five Consecutive Losses Push Archean Chemical Industries Ltd to a New 52-Week Low
For the fifth straight session, Archean Chemical Industries Ltd closed lower, breaching its 52-week low at Rs 424.9 on 5 Nov 2026. This decline comes amid a broader market rally, with the Sensex gaining nearly 2% and several sectoral indices hitting new highs, underscoring the stock’s persistent underperformance.
Read More Announcements 
Signing Of MOU With Andhra Pradesh Economic Development Board
13-Nov-2026 | Source : BSESigning of MOU with Andhra Pradesh Economic Development Board
Announcement under Regulation 30 (LODR)-Earnings Call Transcript
06-Nov-2026 | Source : BSEEarnings Call Transcript
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
06-Nov-2026 | Source : BSEAnalyst/Investor Meet
Corporate Actions 
No Upcoming Board Meetings
Archean Chemical Industries Ltd has declared 125% dividend, ex-date: 05 Jun 26
No Splits history available
No Bonus history available
No Rights history available
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Sep 2026
Shareholding Compare (%holding) 
Promoters
27.5135
Held by 12 Schemes (15.33%)
Held by 99 FIIs (10.41%)
Chemikas Speciality Llp (30.53%)
Hdfc Mutual Fund - Hdfc Multi Cap Fund (4.16%)
11.36%
Quarterly Results Snapshot (Consolidated) - Sep'26 - QoQ
QoQ Growth in quarter ended Sep 2026 is -9.12% vs 8.73% in Jun 2026
QoQ Growth in quarter ended Sep 2026 is 4.50% vs 128.61% in Jun 2026
Half Yearly Results Snapshot (Consolidated) - Sep'25
Growth in half year ended Sep 2025 is 15.97% vs -28.48% in Sep 2024
Growth in half year ended Sep 2025 is 14.25% vs -62.07% in Sep 2024
Nine Monthly Results Snapshot (Consolidated) - Dec'25
YoY Growth in nine months ended Dec 2025 is 12.17% vs -33.53% in Dec 2024
YoY Growth in nine months ended Dec 2025 is -14.45% vs -58.45% in Dec 2024
Annual Results Snapshot (Consolidated) - Mar'26
YoY Growth in year ended Mar 2026 is 3.85% vs -21.73% in Mar 2025
YoY Growth in year ended Mar 2026 is -34.10% vs -49.17% in Mar 2025